We are live on ! Find out more
MSD Partners

MSD Partners Portfolio holdings

AUM $101M Turnover 22.22%
1-Year Est. Return 26.56%
This Fund
S&P 500
This Quarter Est. Return
-27.24%
1 Year Est. Return
-26.56%
3 Year Est. Return
-2.26%
5 Year Est. Return
-28.51%
10 Year Est. Return
+20.37%
AUM
$1.24B
AUM Growth
-$383M
Cap. Flow
-$46M
Cap. Flow %
-3.72%
Top 10 Hldgs %
88.64%
Holding
94
New
1
Increased
4
Reduced
3
Closed
11
Avg Time Held Equity + Options
1.5 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.7 years
Avg Time Held Equity only
1.6 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.8 years

Top Buys

Rank Stock Value
1
APEI icon
American Public Education
APEI
+$1.37M

Sector Composition

Rank Sector Weight
1 Industrials 52.32%
2 Miscellaneous 32.72%
3 Financials 5.18%
4 Healthcare 3.14%
5 Communication Services 2.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HAYW icon
1
Hayward Holdings
HAYW
$3.44B
$635M 51.28%
71,538,085
– –
2021 Q1
6 quarters
HYG icon
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.1B
$300M 24.23%
4,200,000
+875,000
+26% +$66.1M
2020 Q3
8 quarters
BKLN icon
3
PUT
Invesco Senior Loan ETF
BKLN
$5.78B
$44.4M 3.59%
2,200,000
+972,600
+79% +$20.3M
2022 Q2
1 quarter
TCRT icon
4
Alaunos Therapeutics
TCRT
$4.37M
$26.1M 2.11%
101,010
– –
2013 Q2
37 quarters
RNW icon
5
ReNew
RNW
$2.54B
$15.7M 1.27%
2,609,099
– –
2021 Q4
3 quarters
META icon
6
Meta Platforms (Facebook)
META
$1.58T
$13.6M 1.1%
100,000
– –
2022 Q1
2 quarters
TCRT icon
7
CALL
Alaunos Therapeutics
TCRT
$4.37M
$13M 1.05%
50,505
– –
2021 Q3
4 quarters
BTWN
8
DELISTED
Bridgetown Holdings
BTWN
$10.5M 0.85%
1,050,000
– –
2021 Q1
6 quarters
BLEU icon
9
DELISTED
bleuacacia Ltd
BLEU
$9.7M 0.78%
980,000
– –
2022 Q1
2 quarters
GASS icon
10
StealthGas
GASS
$288M
$9M 0.73%
3,516,652
– –
2014 Q1
34 quarters
PTON icon
11
Peloton Interactive
PTON
$2.39B
$8M 0.65%
1,153,846
– –
2022 Q1
2 quarters
IONQ icon
12
IonQ
IONQ
$10.9B
$7.92M 0.64%
1,562,500
– –
2021 Q3
4 quarters
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$3.47T
$7.65M 0.62%
80,000
– –
2022 Q2
1 quarter
ASTL icon
14
Algoma Steel
ASTL
$511M
$5.94M 0.48%
921,800
-4,371,252
-83% -$39M
2021 Q4
3 quarters
XPOF icon
15
Xponential Fitness
XPOF
$202M
$5.74M 0.46%
314,600
– –
2022 Q2
1 quarter
SRSAU
16
DELISTED
Sarissa Capital Acquisition Corp Unit
SRSAU
$5.25M 0.42%
524,900
– –
2020 Q4
7 quarters
ICD icon
17
DELISTED
Independence Contract Drilling
ICD
$5M 0.4%
1,667,756
– –
2018 Q4
15 quarters
CCVI.U
18
DELISTED
Churchill Capital Corp VI Units
CCVI.U
$4.94M 0.4%
500,000
– –
2021 Q1
6 quarters
WFC icon
19
Wells Fargo
WFC
$243B
$4.52M 0.37%
112,325
– –
2020 Q1
10 quarters
CMA icon
20
DELISTED
Comerica
CMA
$4.34M 0.35%
61,000
– –
2020 Q1
10 quarters
TLSI icon
21
TriSalus Life Sciences
TLSI
$151M
$3.97M 0.32%
400,000
– –
2022 Q1
2 quarters
JPM icon
22
JPMorgan Chase
JPM
$861B
$3.92M 0.32%
37,500
– –
2013 Q2
37 quarters
CMRX icon
23
DELISTED
Chimerix
CMRX
$3.86M 0.31%
2,000,000
– –
2021 Q3
4 quarters
MTB icon
24
M&T Bank
MTB
$30.7B
$3.85M 0.31%
21,850
– –
2021 Q2
5 quarters
IHRT icon
25
iHeartMedia
IHRT
$85.1M
$3.62M 0.29%
493,794
– –
2019 Q3
12 quarters

Similar funds

MSD Partners's Q3 2022 Portfolio in Review

As of Q3 2022, MSD Partners held 94 positions worth $1.24B, down 24% from $1.62B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

MSD Partners withdrew a net $46M in Q3 2022, closing 11 positions and reducing 3 holdings. Its most notable exit was Ocular Therapeutix, an estimated $4.09M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 52% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, MSD Partners opened a new position in American Public Education worth $1M.

  • MSD Partners's largest Q3 2022 buy was American Public Education: 110,000 shares worth $1M.
  • MSD Partners's biggest Q3 2022 reduction was Algoma Steel, cutting an estimated $39M.
  • MSD Partners fully exited Ocular Therapeutix in Q3 2022, selling an estimated $4.09M.
  • MSD Partners's ten largest holdings make up 89% of its $1.24B portfolio in Q3 2022.
  • MSD Partners opened 1 new position and closed 11 in Q3 2022.
  • MSD Partners's portfolio value fell 24% quarter-over-quarter to $1.24B.

Based on MSD Partners's 13F filing for Q3 2022, filed 14 Nov 2022.